Entera Bio Ltd ENTX.OQ, ENTX.O is expected to report results on August 11 (estimated) for the period ending June 30 2025
LSEG's mean analyst estimate for Entera Bio Ltd is for a loss of 11 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Entera Bio Ltd is $10.00, about 82% above its last closing price of $1.80
This summary was machine generated August 8 at 13:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments